Literature DB >> 15905314

CYP2D6 genotyping by a multiplex primer extension reaction.

Johanna Sistonen1, Silvia Fuselli, Antti Levo, Antti Sajantila.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15905314     DOI： 10.1373/clinchem.2004.046466

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  27 in total

1.  BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors.

Authors:  Caterina Chianella; Daniela Gragnaniello; Pierpaolo Maisano Delser; Maria Francesca Visentini; Elisabetta Sette; Maria Rosaria Tola; Guido Barbujani; Silvia Fuselli
Journal:  Eur J Clin Pharmacol       Date:  2011-06-01       Impact factor: 2.953

2.  Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone.

Authors:  Juha Grönlund; Teijo I Saari; Nora M Hagelberg; Pertti J Neuvonen; Klaus T Olkkola; Kari Laine
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

3.  Analysis of genetic variations in CYP2C9, CYP2C19, CYP2D6 and CYP3A5 genes using oligonucleotide microarray.

Authors:  Yuanyuan Dong; Huasheng Xiao; Qi Wang; Chunxiu Zhang; Xiuming Liu; Na Yao; Haihui Sheng; Haiyan Li
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  Alternative reliable method for cytochrome P450 2D6 poor metabolizers genotyping.

Authors:  E Pindurová; A Zourková; J Zrůstová; J Juřica; A Pavelka
Journal:  Mol Biotechnol       Date:  2013-01       Impact factor: 2.695

5.  Fatal venlafaxine poisonings are associated with a high prevalence of drug interactions.

Authors:  Terhi Launiainen; Ilpo Rasanen; Erkki Vuori; Ilkka Ojanperä
Journal:  Int J Legal Med       Date:  2010-04-30       Impact factor: 2.686

6.  Miconazole oral gel increases exposure to oral oxycodone by inhibition of CYP2D6 and CYP3A4.

Authors:  Juha Grönlund; Teijo I Saari; Nora Hagelberg; Pertti J Neuvonen; Klaus T Olkkola; Kari Laine
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

7.  Elimination of intravenous oxycodone in the elderly: a pharmacokinetic study in postoperative orthopaedic patients of different age groups.

Authors:  Antti Liukas; Kristiina Kuusniemi; Riku Aantaa; Petri Virolainen; Mikko Neuvonen; Pertti J Neuvonen; Klaus T Olkkola
Journal:  Drugs Aging       Date:  2011-01-01       Impact factor: 3.923

8.  Developing and Evaluating the HRM Technique for Identifying Cytochrome P450 2D6 Polymorphisms.

Authors:  Hsiu-Chin Lu; Ya-Sian Chang; Chun-Chi Chang; Ching-Hsiung Lin; Jan-Gowth Chang
Journal:  J Clin Lab Anal       Date:  2014-05-05       Impact factor: 2.352

9.  Apnea and oxygen desaturations in children treated with opioids after adenotonsillectomy for obstructive sleep apnea syndrome: a prospective pilot study.

Authors:  Justin D Khetani; Parvaz Madadi; Doron D Sommer; Desigen Reddy; Johanna Sistonen; Colin J D Ross; Bruce C Carleton; Michael R Hayden; Gideon Koren
Journal:  Paediatr Drugs       Date:  2012-12-01       Impact factor: 3.022

10.  Rifampicin markedly decreases the exposure to oral and intravenous tramadol.

Authors:  Tuukka Saarikoski; Teijo I Saari; Nora M Hagelberg; Mikko Neuvonen; Pertti J Neuvonen; Mika Scheinin; Klaus T Olkkola; Kari Laine
Journal:  Eur J Clin Pharmacol       Date:  2012-12-15       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.